Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management
| DGX Stock | USD 162.66 0.66 0.40% |
Slightly above 55% of Quest Diagnostics' investor base is interested to short. The analysis of overall sentiment of trading Quest Diagnostics Incorporated stock suggests that many investors are impartial at this time. Quest Diagnostics' investing sentiment can be driven by a variety of factors including economic data, Quest Diagnostics' earnings reports, geopolitical events, and overall market trends.
Quest |
Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Ques
Read at businesswire.com
 |
Quest Diagnostics Current Investor Sentiment
Panic Vs Confidence
45
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Quest Diagnostics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Quest Diagnostics Incorporated.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Quest Diagnostics Historical Investor Sentiment
Investor biases related to Quest Diagnostics' public news can be used to forecast risks associated with an investment in Quest. The trend in average sentiment can be used to explain how an investor holding Quest can time the market purely based on public headlines and social activities around Quest Diagnostics Incorporated. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Quest Diagnostics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Quest Diagnostics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Quest Diagnostics news discussions. The higher the estimate score, the more favorable the investor's outlook on Quest Diagnostics.
Quest Diagnostics Fundamental Analysis
We analyze Quest Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Quest Diagnostics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Quest Diagnostics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Quest Diagnostics stock to make a market-neutral strategy. Peer analysis of Quest Diagnostics could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics with similar companies.
Peers
Quest Diagnostics Related Equities
| TWST | Twist Bioscience | 1.78 | ||||
| MTD | Mettler Toledo | 0.63 | ||||
| SHC | Sotera Health | 0.53 | ||||
| IDXX | IDEXX Laboratories | 0 | ||||
| RVTY | Revvity | 0.08 | ||||
| A | Agilent Technologies | 0.12 | ||||
| CRL | Charles River | 0.27 | ||||
| IQV | IQVIA Holdings | 0.29 | ||||
| WAT | Waters | 0.48 | ||||
| ICLR | ICON PLC | 1.22 |
Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.